Kiran Lassi

Summary

Publications

  1. ncbi Drug development for metastatic castration-resistant prostate cancer: current status and future perspectives
    Kiran Lassi
    Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC, USA
    Future Oncol 7:551-8. 2011
  2. ncbi Update on castrate-resistant prostate cancer: 2010
    Kiran Lassi
    Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, District of Columbia 20007, USA
    Curr Opin Oncol 22:263-7. 2010
  3. ncbi Emerging therapies in castrate-resistant prostate cancer
    Kiran Lassi
    Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, District of Columbia, USA
    Curr Opin Oncol 21:260-5. 2009

Collaborators

Detail Information

Publications3

  1. ncbi Drug development for metastatic castration-resistant prostate cancer: current status and future perspectives
    Kiran Lassi
    Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC, USA
    Future Oncol 7:551-8. 2011
    ..This article reviews current data on the novel therapeutics demonstrating activity in metastatic castration-resistant prostate cancer and their future role in the treatment of this disease with a poor prognosis...
  2. ncbi Update on castrate-resistant prostate cancer: 2010
    Kiran Lassi
    Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, District of Columbia 20007, USA
    Curr Opin Oncol 22:263-7. 2010
    ....
  3. ncbi Emerging therapies in castrate-resistant prostate cancer
    Kiran Lassi
    Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, District of Columbia, USA
    Curr Opin Oncol 21:260-5. 2009
    ....